[Platinum salts: cytotoxic mechanisms of action, mechanisms of resistance of cancer cells, interactions with ionizing radiation, specificity of carboplatin]
- PMID: 11082717
[Platinum salts: cytotoxic mechanisms of action, mechanisms of resistance of cancer cells, interactions with ionizing radiation, specificity of carboplatin]
Abstract
Platinum compounds primarily act by damaging cellular targets inducing direct or indirect DNA alterations, and cytoplasmic proteins modifications. Molecular and cellular mechanisms of platinum resistance include increase of DNA repair, amplification of detoxifying proteins, modification of platinum transport, and alteration of oncogenes expression. This overview will describe those preclinical constatations related to cisplatin and will focus on carboplatin specificity.
Similar articles
-
Analysis of cytotoxicities of platinum compounds.Cancer Chemother Pharmacol. 2006 Jan;57(2):257-67. doi: 10.1007/s00280-005-0041-4. Epub 2005 Jul 19. Cancer Chemother Pharmacol. 2006. PMID: 16028101
-
Insights into mechanisms of cisplatin resistance and potential for its clinical reversal.Pharmacotherapy. 1996 Jan-Feb;16(1):16-39. Pharmacotherapy. 1996. PMID: 8700790 Review.
-
Efficient nucleotide excision repair of cisplatin, oxaliplatin, and Bis-aceto-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) platinum intrastrand DNA diadducts.Cancer Res. 1999 Aug 15;59(16):3968-71. Cancer Res. 1999. PMID: 10463593
-
Cisplatin and platinum drugs at the molecular level. (Review).Oncol Rep. 2003 Nov-Dec;10(6):1663-82. Oncol Rep. 2003. PMID: 14534679 Review.
-
Mechanisms of resistance to cisplatin and carboplatin.Crit Rev Oncol Hematol. 2007 Jul;63(1):12-31. doi: 10.1016/j.critrevonc.2007.02.001. Epub 2007 Mar 1. Crit Rev Oncol Hematol. 2007. PMID: 17336087 Review.